Combination Teriparatide and Raloxifene Therapy for Postmenopausal Osteoporosis: Results From a 6-Month Double-Blind Placebo-Controlled TrialChad Deal, John H. Krege, Elliott N. Schwartz et al.|Journal of Bone and Mineral Research|2005Cited by 222
Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive AgentFelicia Cosman, John H. Krege, Emmett V. Glass et al.|The Journal of Clinical Endocrinology & Metabolism|2009Cited by 172
Reduced risk of back pain following teriparatide treatment: a meta-analysisMichael C. Nevitt, John H. Krege, Peiqi Chen et al.|Osteoporosis International|2005Cited by 132